Infant allergies impacted by their mode of birth
Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report the effect is more pronounced in children of Asian
Researchers have found a causal link between caesarean section birth, low intestinal microbiota and peanut sensitivity in infants, and they report the effect is more pronounced in children of Asian
Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy immunotherapy, has announced, that following a competitive tender process, BDO LLP has been appointed as its external
If you’ve noticed your allergies getting worse every spring, you are not alone, allergy experts say. The spring allergy season — which takes place from February to May each year and impacts roughly
A year into the pandemic, allergy season is back, and worse than before. Doctors told CBS2 that their waiting rooms are full of people sniffling and coughing, terrified they have
An estimated 6 million Americans may suffer from peanut allergies. Tiny amounts of peanut protein can lead to hives, itching, tingling in the mouth, shortness of breath or nausea within
It’s the season of sniffling and sneezing, but this year as Manitobans continue to deal with COVID-19, allergy symptoms can leave many wondering if they should be more concerned. More people
Allergic diseases are on the rise all over the world and appear in increasingly more complex and serious forms. It is estimated that between 20% – 30% of the Portuguese
Allergy season can bring a whole host of unpleasant symptoms, like a runny nose, sneezing, and itchy, watery eyes. And, if you’re feeling more tired than usual, you’re not alone. “This is
Exposure to pollen can raise your risk of developing COVID-19, and it isn’t just a problem for people with allergies, new research released March 9 shows. Plant physiologist Lewis Ziska, a
Allergy Therapeutics plc (LON:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, has announced that Manuel Llobet, Chief Executive Officer, Nick Wykeman, Chief Financial Officer, and Alan Bullimore,